C3 and COVID-19: Severe COVID-19 with respiratory failure is characterized by a diffuse lung microvascular injury mediated by complement activation indicated by both the presence of significant serum levels and deposits in lung microvasculature of terminal complement components C5b-9 (membrane attack complex), C3b, and C4d, [87,90,91,92].